Among the affected startups were Fermbox, Phyxx 44, Ajitha Prodrug, Galore TX, Ikesia, Immunitas, and Yokogawa, along with others like Atrimed Pharma, 4basecare, Anabio, Anava Bio, Pandorium ...

Piramal Pharma Ltd share price was down by -1.50% ... this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and ...

Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic drugs.

Several other startups were also affected (Including Atrimed pharma, 4basecare, Anabio, Anava bio, Pandorium, Oxonexe Presude Lifesciences, Zhichu among others," the statement read. The fire in ...

Other start-ups that were affected included Atrimed Pharma, 4basecare, Anabio, Anava Bio, Pandorium, Oxonexe Presude Lifesciences, and Zhichu.

J B Chemicals & Pharmaceuticals (JBC ... Subsequently, the Companys subsidiary J.B. Healthcare Pvt. Ltd., Jersey, has been dissolved. With a view to return surplus cash and pursuant to authority ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in drugs ...

Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...

Sun Pharmaceutical Industries or Sun Pharma is ... on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and ...

Ajanta Pharma is a specialty pharmaceutical formulation ... crore.The Scheme of Amalgamation and Arrangement of Gabs Investments Pvt. Ltd. with the Company which was filed by the Company with ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...